2021年最新SCI期刊影响因子查询系统
EXPERT OPINION ON INVESTIGATIONAL DRUGS 期刊详细信息
基本信息
期刊名称 | EXPERT OPINION ON INVESTIGATIONAL DRUGS EXPERT OPINION ON INVESTIGATIONAL DRUGS |
---|---|
期刊ISSN | 1354-3784 |
期刊官方网站 | http://www.tandfonline.com/toc/ieid20/current |
是否OA | 否 |
出版商 | Taylor and Francis Ltd. |
出版周期 | Monthly |
始发年份 | 1994 |
年文章数 | 80 |
最新影响因子 | 6.498(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | PHARMACOLOGY & PHARMACY 药学2区 | 否 | 是 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 3.14 | 1.076 | 0.737 |
Medicine Pharmacology (medical) |
47 / 232 | 79% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmacology |
80 / 300 | 73% |
补充信息
自引率 | 1.80% |
---|---|
H-index | 90 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3784%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/eoid |
---|---|
收稿范围 | Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development. The Editors welcome: Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies Drug Evaluations reviewing the clinical and pharmacological data on a particular drug Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |